Instructions for Migrenium (caffeine, paracetamol)
English Product Name
Migrenium
Release Form Migrenium
Coated tablets
Description Migrenium
Tablets covered with a film coating of white or almost white, oval, biconvex shape, with one side of risk; two layers, the color of the nucleus without the coating of white or almost white, are visible in the cross-section.
1 tab
paracetamol 0.5 g
caffeine 0.065 g
Accessories: potato starch, microcrystalline cellulose, sodium croscarmellose, hyprolose, silicon colloidal dioxide, magnesium stearate.
Envelope composition: hyprolose, copovidone, talc, titanium dioxide, silicone emulsion (50% p-r).
ATX codes
N02BE71 Paracetamol in combination with psycholeptics
Clinical and pharmacological groups / Group affiliation
Analgesic antipyretic
Active ingredient Migrenium
caffeine
paracetamol
Pharmacotherapeutic group caffeine, paracetamol
Analgesic non-narcotic (psychostimulant+non-narcotic analgesic)
Pharmacological effect
A combination drug.
Paracetamol is an analgesic antipyretic. It has analgesic, antipyretic and mild anti-inflammatory effects. The mechanism of action is related to inhibition of prostaglandin synthesis, predominantly affecting the center of thermoregulation in the hypothalamus. The absence of any effect on the synthesis of prostaglandins in peripheral tissues causes it to have no negative effect on water-salt metabolism (sodium and water retention) and the gastrointestinal mucosa.
Testimony caffeine, paracetamol
Pain syndrome (mild to moderate): Headache; migraine; ossalgia; myalgia; neuralgia; arthralgia; algodysmenorrhea; toothache.
Symptomatic treatment of colds, influenza, including fever.
Method of use, course and dosage caffeine, paracetamol
Inside adults - two tablets. four times a day with an interval of at least four hours. The maximum daily dose - eight tabs.
Duration of application - not more than ten days.
- Nosology (ICD codes)
- G43
- Migraine
- J06.9
- Acute upper respiratory infection, unspecified
- J10
- Influenza due to identified seasonal influenza virus
- K08.8
- Other specified changes in teeth and their supporting apparatus (including toothache)
- M25.5
- Pain joint
- M79.1
- Myalgia
- M79.2
- Neuralgia and neuritis, unspecified
- N94.4
- Primary dysmenorrhea
- N94.5
- Secondary dysmenorrhoea
- R50
- Fever of unknown origin
- R51
- Headache
- R52.0
- Acute pain
- R52.2
- Other persistent pain (chronic)
Pharmacotherapy group caffeine, paracetamol
An analgesic non-narcotic (psychostimulant+non-narcotic analgesic).
